Norwich Clinical Research Associates Ltd. (NCRA) Clinical Pharmacology and Medical Monitoring teams combine the best of academic and industry clinical research experience.

NCRA can conduct your Clinical Pharmacology Trials and provide experienced Medical Monitors.

We are skilled in working with you to bridge pre-clinical pharmacology/toxicology development with the clinical development of your product.  We can assist you through all phases of your product’s strategic development from IND or IDE submission through your NDA, 510(K) or PMA submission.  Biotechnology, venture start-up, and/or international companies with limited experience in product development in the U.S. will find our expert services in consulting and clinical pharmacology extremely useful.

Our clinical pharmacology group will work closely with you to advance your product in line with your specific business objectives.

Phase 1 - 3 Clinical Trials:

• consult and design,
  
• manage and medically monitor,
  
• interpret and write regulatory acceptable final reports and manuscripts.

Phase 4 Clinical Trials: 

          For your Phase 4 outcomes and pharmacoeconomic trials we will:

• plan, design, and conduct outcomes and pharmacoeconomic studies/trials in an ambulatory health care setting,

• apply appropriate models for cost/benefit analysis,

• prepare clinically oriented reports, and

• provide Medical Monitoring services.